Effect of Oats on Lipid Profile

February 25, 2015 updated by: PepsiCo Global R&D

A Randomized Controlled Trial to Evaluate the Efficacy of 3 g of Soluble Fiber From Oats on the Lipid Profile of Men and Women With Elevated Lipid Levels Aged Between 20 and 50 Years

A randomized control trial to assess the effect of oats on lipid profile of mildly hypercholesterolemic subjects. Subjects consumed 35g of oats twice daily (total of 70g / day) in place of carbohydrates as part of their usual diet. 70 grams of oats provide 3 grams of soluble fiber. Control group consumed the usual diet. Subjects followed up for 4 weeks. In total 3 assessment visits of the subjects planned for the study period.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women between 20 and 50 years old
  • Total Cholesterol: ≥ 200 mg/dL and < 240mg/dL
  • Availability and willingness to follow study protocol
  • Stable body weight for previous 3 months (not more than 5% weight change)

Exclusion Criteria:

  • Subjects already on lipid lowering drugs
  • LDL-c > 190 mg/dL
  • Total cholesterol <200 mg/dL and >240 mg/dL
  • Subjects with serum creatinine levels > 1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse
  • Baseline Triglycerides: > 300 mg/dL
  • Diabetes (Type 1 or Type 2) as diagnosed by a physician
  • Uncontrolled hyperthyroidism (as per physician's discretion)
  • Uncontrolled hypertension (as per physician's discretion)
  • Acute infections or chronic debilitating diseases like tuberculosis, malignancy, HIV infection etc. Any life threatening serious disorder of the liver, kidneys, heart, lungs or other organs by history
  • Irritable bowel syndrome by history
  • Unwillingness to give written informed consent for participation in the study.
  • Pregnancy & lactation (by history)
  • Severe end organ damage
  • Subjects with allergy to oats
  • Heavy smokers (smoking more than 5 cigarettes per day)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oats
70 grams oats
Placebo Comparator: usual diet and exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
reduction of total cholesterol
Time Frame: 4 weeks
4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 4 weeks
4 weeks
Triglycerides
Time Frame: 4 weeks
4 weeks
LDL-c
Time Frame: 4 weeks
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anoop Misra, MD, MBBS, Fortis Clinical Research Limited

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

February 25, 2015

First Submitted That Met QC Criteria

February 25, 2015

First Posted (Estimate)

March 3, 2015

Study Record Updates

Last Update Posted (Estimate)

March 3, 2015

Last Update Submitted That Met QC Criteria

February 25, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • PEP-1205

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mildly Hypercholesterolemic Subjects

Clinical Trials on Oats

Subscribe